ArticleNature medicine2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Metabolic reprogramming is associated with symptomatic COVID-19: a serum proteomics and causal inference study identifying ALDOB and glycerol as candidate metabolic correlates.Frontiers in microbiology · 2026Article
- Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort.Scientific reports · 2023Article
- Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection.Clinical and translational medicine · 2022Article
- Transcriptional differences between coronavirus disease 2019 and bacterial sepsis.Virology journal · 2022Article
- Gene Set Enrichment Analysis Reveals That Fucoidan Induces Type I IFN Pathways in BMDC.Nutrients · 2022Article
- The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients.Biomedicines · 2022Article
- Immune response induced by novel coronavirus infection.Frontiers in cellular and infection microbiology · 2022Review
- Personal observations on COVID-19 and the conduct and application of biomedical science.Interface focus · 2021Article
- Individual's daily behaviour and intergenerational mixing in different social contexts of Kenya.Scientific reports · 2021Article
- A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients.Pediatric transplantation · 2021Article
- An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses.iScience · 2021Article
- Article
- Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal.bioRxiv : the preprint server for biology · 2021Article
- Human marginal zone B cell development from early T2 progenitors.The Journal of experimental medicine · 2021Article
Corrections and comments
- Erratum for
Authors and funding
50 authors.
Adam G Laing *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Anna Lorenc *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-1406-7607
Irene Del Molino Del Barrio *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Abhishek Das *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-8798-035X
Matthew Fish *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0001-6462-3889
Leticia Monin *The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-4951-8105
Miguel Muñoz-Ruiz *The Francis Crick Institute, London, UK.
Duncan R McKenzie *The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0961-8846
Thomas S Hayday *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Isaac Francos-Quijorna *Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.
Shraddha Kamdar *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Magdalene JosephPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Daniel DaviesPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Richard DavisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Aislinn JenningsPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-6954-5717
Iva ZlatarevaPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Pierre VantouroutPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0001-7287-5517
Yin WuPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0003-4080-3935
Vasiliki SofraPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Florencia CanoThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0695-7551
Maria GrecoThe Francis Crick Institute, London, UK.
Efstathios TheodoridisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Joshua D FreedmanPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Sarah GeePeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-2997-6563
Julie Nuo En ChanComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Sarah RyanDepartment of Inflammation Biology, King's College London, London, UK.
Eva Bugallo-BlancoComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-4350-0625
Pärt PetersonMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0001-6755-791X
Kai KisandMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-5426-4648
Liis HaljasmägiMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Loubna ChadliCenter for Therapeutic Innovation in Immuno-inflammation, Servier, France.
Philippe MoingeonCenter for Therapeutic Innovation in Immuno-inflammation, Servier, France.ORCID http://orcid.org/0000-0002-2380-9983
Lauren MartinezInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-5830-2496
Blair MerrickCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-6061-6064
Karen BisnauthsingCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Kate BrooksInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mohammad A A IbrahimImmunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-0116-597X
Jeremy MasonThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2796-5123
Federico Lopez GomezThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-7138-3542
Kola BabalolaThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
Sultan Abdul-JawadComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
John CasonDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Christine MantDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Jeffrey SeowDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Carl GrahamDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Katie J DooresDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Francesca Di RosaInstitute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.
Jonathan EdgeworthCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Manu Shankar-HariPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. manu.shankar-hari@kcl.ac.uk.ORCID http://orcid.org/0000-0002-5338-2538
Adrian C HaydayPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.ORCID http://orcid.org/0000-0002-9495-5793
Funding
No grant is acknowledged in the PubMed record.
Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s41591-020-01186-5.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.